Molecular Templates News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Molecular templates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Molecular Templates Today - Breaking & Trending Today

Molecular Templates, Inc. (NASDAQ:MTEM) Short Interest Down 21.9% in May

Molecular Templates, Inc. (NASDAQ:MTEM – Get Free Report) saw a large drop in short interest during the month of May. As of May 15th, there was short interest totalling 132,100 shares, a drop of 21.9% from the April 30th total of 169,100 shares. Based on an average daily volume of 75,500 shares, the short-interest ratio […] ....

United States , Securities Exchange Commission , Molecular Templates Inc , Silverarc Capital Management , Molecular Templates , Get Free Report , Capital Management , Free Report , Molecular Templates Daily ,

Molecular Templates, Inc. (NASDAQ:MTEM) Shares Sold by Monashee Investment Management LLC

Molecular Templates, Inc. (NASDAQ:MTEM) Shares Sold by Monashee Investment Management LLC
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United States , Silverarc Capital Management , Monashee Investment Management , Molecular Templates Inc , Molecular Templates Company Profile , Exchange Commission , Molecular Templates , Free Report , Investment Management , Templates Trading Down , Get Free Report , Molecular Templates Daily ,

Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial

Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial
bmj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bmj.com Daily Mail and Mail on Sunday newspapers.

United States , Eteläuomen Läi , South Korea , Jin Wang , Genentechf Hoffmann , Asher Biotherapeutics , Daiichi Sankyo , Chipscreen Biosciences , Bristol Myers Squibb , Ashfield Medcomms , Merck Biopharm , Merck Serono , Samsung Bioepis , Lyell Immunopharma , Calithera Biosciences , Eli Lilly , Keymed Biosience , Astellas Pharma , Asiav Europe , Dewan Zang , Merck Biopharma , Aeglea Biotherapeutics , Hutchinson Medipharma Incyte , Lynda Mcevoy , Pierre Fabre , Simon Lancaster ,

MTEM Stock Earnings: Molecular Templates Beats EPS, Beats Revenue for Q1 2024

MTEM Stock Earnings: Molecular Templates Beats EPS, Beats Revenue for Q1 2024
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Market News , Stock Advice , Molecular Templates , Molecular Templates Beats , Beats Revenue ,